Tempus
Tempus is a biotechnology company that leverages artificial intelligence and data analytics to advance precision medicine, primarily in oncology and other therapeutic areas. It makes money by providing genomic sequencing, clinical data aggregation, and AI-driven insights to healthcare providers, researchers, and pharmaceutical companies to support tailored treatment plans, drug development, and clinical trials.
The ten most recent trades of Tempus in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Jan 17, 2025 | Buy | $5,599,197 | 3.90% | 0.09% |
Jan 17, 2025 | Buy | $5,599,197 | 3.90% | 0.09% |
Jan 17, 2025 | Buy | $5,599,197 | 3.90% | 0.09% |
Jan 13, 2025 | Buy | $9,260,346 | 7.35% | 0.15% |
Dec 18, 2024 | Buy | $10,723,290 | 8.24% | 0.15% |
Dec 17, 2024 | Buy | $10,867,047 | 8.41% | 0.15% |
Dec 13, 2024 | Buy | $3,482,305 | 2.60% | 0.05% |
Dec 11, 2024 | Buy | $14,646,786 | 12.38% | 0.21% |
Dec 09, 2024 | Buy | $3,538,916 | 2.63% | 0.05% |
Dec 06, 2024 | Buy | $7,390,274 | 5.51% | 0.10% |